0000059478-18-000225.txt : 20180919 0000059478-18-000225.hdr.sgml : 20180919 20180919174750 ACCESSION NUMBER: 0000059478-18-000225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180917 FILED AS OF DATE: 20180919 DATE AS OF CHANGE: 20180919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zulueta Alfonso G CENTRAL INDEX KEY: 0001596336 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 181078351 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LILLY ELI & CO CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 4 1 wf-form4_153739365291067.xml FORM 4 X0306 4 2018-09-17 0 0000059478 LILLY ELI & CO LLY 0001596336 Zulueta Alfonso G LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 1 0 0 SVP & President, Lilly Int'l Common Stock 2018-09-17 4 S 0 3000 105.61 D 55224 D Common Stock 2018-09-18 4 S 0 3000 107 D 52224 D Common Stock 4473 I 401(k) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2018. Bronwen Mantlo for Alfonso G. Zulueta, authorization on file 2018-09-19 EX-24 2 zuluetapoa.htm ZULUETA_POA
Alfonso G. Zulueta
Lilly Corporate Center
Indianapolis, Indiana  46285



Securities and Exchange Commission
Washington, D.C.  20549

AuthorizationRegardingReportingForms

I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5 (including any amendments thereto) covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder:

    Michael J. Harrington, Lilly Corporate Center, Indianapolis, Indiana

    Bronwen L. Mantlo, Lilly Corporate Center, Indianapolis, Indiana

    Crystal T. Williams, Lilly Corporate Center, Indianapolis, Indiana

This authorization and designation shall remain in effect until a written revocation is signed by me and provided to the Commission.


Date: June 28, 2018



/s/ Alfonso G. Zulueta